Random triples
Subject | Object |
---|---|
gptkb:Novavax | 90% in clinical trials |
gptkb:Moderna | 94.1% for COVID-19 |
gptkb:Biontech | high efficacy against variants |
gptkb:Biontech | 95% against COVID-19 |
gptkb:Biontech | 95% (COVID-19) |
Subject | Object |
---|---|
gptkb:Novavax | 90% in clinical trials |
gptkb:Moderna | 94.1% for COVID-19 |
gptkb:Biontech | high efficacy against variants |
gptkb:Biontech | 95% against COVID-19 |
gptkb:Biontech | 95% (COVID-19) |